The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations
1990

The 5T Mouse Model of Multiple Myeloma and c-myc Oncogene Rearrangement

publication Evidence: moderate

Author Information

Author(s): J. Radl, Y.A. Punt, M.H.M. van den Enden-Vieveen, P.A.J. Bentvelzen, M.H.C. Bakkus, Th.W. van den Akker, R. Benner

Primary Institution: TNO Institute for Experimental Gerontology

Hypothesis

Does the 5T mouse model of multiple myeloma contain c-myc oncogene abnormalities similar to those found in other malignancies?

Conclusion

The study found that c-myc rearrangement was present only in the 24th generation of the 5T2 multiple myeloma line and not in earlier generations.

Supporting Evidence

  • Rearrangement of the c-myc oncogene was found only in the 5T2 MM transplantation line in the 24th generation.
  • None of the seven other MM lines from earlier generations showed c-myc abnormalities.
  • The 5T mouse model closely resembles human multiple myeloma in several aspects.

Takeaway

Scientists studied mice with multiple myeloma to see if they had changes in a gene called c-myc, which is often involved in cancer. They found that only one specific line of mice had these changes, suggesting it might happen later in the disease.

Methodology

The study involved using male and female C57BL/KaLwRij mice, analyzing bone marrow and spleen cells for c-myc rearrangements through Southern blot analysis.

Limitations

The study only examined specific transplantation lines and did not explore all potential structural abnormalities.

Participant Demographics

C57BL/KaLwRij mice, both male and female, were used in the study.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication